Something is brewing.
We're building autonomous AI systems that research, learn, and improve themselves. They read scientific literature at scale, build their own knowledge structures, identify what hasn't been studied yet, and generate original research hypotheses.
Then they do it again. And again. Each cycle sharper than the last.
Because the pharmaceutical industry takes itself extremely seriously, and we think that's part of the problem. The best ideas don't come from boardrooms with mahogany tables. They come from someone at 3am who asks a stupid question and then can't let it go.
We put the "ph" in pharmaceutical and the "art" in, well, you get it. It's loud, it's unexpected, and once it's out there, everyone notices.
Multiple self-improving research agents. Different architectures. Different specializations. They don't just search the internet. They build structured knowledge graphs, identify gaps in existing research, cross-reference across millions of published papers, and synthesize findings that no single human researcher could assemble alone.
One agent's theoretical output becomes another agent's operational input. They verify each other. They challenge each other. They don't agree on everything, and that's the point.
We're not talking about that yet.
But it's gas.
Active research. Stealth mode. Controlled detonation pending.
If you know, you know. If you don't, you will.